Biotech Values

[mcbio]

As usual, risk/reward. The current price is good, perhaps even better than good, but any potential payoff just seems too far down the pike to justify tying up the $$$.

I think the odds are pretty good that the ADHD trial fails, given prior results, and that's the next binary event I believe so I'll definitely be waiting until at least after that before I consider shares.